Check-Cap Ltd. (MBAI) - Total Assets
Based on the latest financial reports, Check-Cap Ltd. (MBAI) holds total assets worth $7.49 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore MBAI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Check-Cap Ltd. - Total Assets Trend (2021–2025)
This chart illustrates how Check-Cap Ltd.'s total assets have evolved over time, based on quarterly financial data. See what is Check-Cap Ltd.'s book value for net asset value and shareholders' equity analysis.
Check-Cap Ltd. - Asset Composition Analysis
Current Asset Composition (December 2025)
Check-Cap Ltd.'s total assets of $7.49 Million consist of 2.9% current assets and 97.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $726.00K | 9.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Check-Cap Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Check-Cap Ltd. market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Check-Cap Ltd.'s current assets represent 2.9% of total assets in 2025, a decrease from 94.8% in 2021.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 47.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 9.7% of total assets.
Check-Cap Ltd. Competitors by Total Assets
Key competitors of Check-Cap Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Clinica Baviera
MC:CBAV
|
Spain | €228.01 Million |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.41 Billion |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
|
China | CN¥2.35 Billion |
|
SCOPE FLUIDICS SA ZY-10
F:S84
|
Germany | €195.94 Million |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩40.77 Billion |
|
Predilife
PA:ALPRE
|
France | €1.31 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
Check-Cap Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.05 | 0.15 | 19.66 |
| Quick Ratio | 0.05 | 0.15 | 19.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.83 Million | $-1.55 Million | $17.04 Million |
Check-Cap Ltd. - Advanced Valuation Insights
This section examines the relationship between Check-Cap Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.08 |
| Latest Market Cap to Assets Ratio | 1.08 |
| Asset Growth Rate (YoY) | 1885.7% |
| Total Assets | $7.49 Million |
| Market Capitalization | $8.12 Million USD |
Valuation Analysis
Above Book Valuation: The market values Check-Cap Ltd.'s assets above their book value (1.08x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Check-Cap Ltd.'s assets grew by 1885.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Check-Cap Ltd. (2021–2025)
The table below shows the annual total assets of Check-Cap Ltd. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $7.49 Million | +1885.68% |
| 2024-12-31 | $377.00K | -98.49% |
| 2023-12-31 | $25.02 Million | -44.95% |
| 2022-12-31 | $45.44 Million | -18.36% |
| 2021-12-31 | $55.66 Million | -- |
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.